Status:
UNKNOWN
Magnesium Sulphate in Oblique Subcostal TAP Block
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain Management
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to evaluate the effect of adding different doses of MgSO4 to bupivacaine via OSCTAB block on postoperative pain control for 24 hours in patients scheduled for LC.
Detailed Description
Laparoscopic cholecystectomy (LC) is a gold standard for management of gallbladder stones. Early and easily recovery, less operative morbidities, less postoperative pain, improved cosmetics, less hosp...
Eligibility Criteria
Inclusion
- • Patients programmed for elective LC.
- American society of anesthesiologists (ASA) physical state I or II.
- Age over 18 years and less than 60 years old.
- Patients of both sex are included in the study.
Exclusion
- • Patient refusal.
- Known hypersensitivity to the study drugs.
- Body Mass Index \> 40 kg/m2.
- Inability to accurately describe postoperative pain to investigators.
- Opioid tolerance or dependence.
- Preexisting history of chronic pain.
- History of renal, liver, cardiac, neuropsychiatric disorder problems.
- Bleeding or coagulation abnormality.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06148168
Start Date
January 1 2024
End Date
February 20 2025
Last Update
November 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.